Preview

Obstetrics, Gynecology and Reproduction

Advanced search

FEMALE SEXUAL DYSFUNCTION

https://doi.org/10.17749/2070-4968.2015.9.4.086-088

Full Text:

Abstract

Female sexual dysfunction affect up to 43% of women causing a "distress" or a psychological strain for the patients. A variety of chronic diseases in addition to menopause and different drugs represents the risk factors to a female sexual dysfunction. Since 2015 the FDA has approved Flibanserin for the treatment of female libido although several other drugs have been proven efficacious.

About the Authors

C. DADAK
University Clinic of obstetrics and gynecology, Vienna, Austria
Austria
University Clinic of obstetrics and gynecology Center for teaching


M. BAYERLE-EDE
Medical University of Vienna, Austria
Austria
Medical University of Vienna Department of internal medicine III, Department of Endocrinology and metabolism


For citation:


DADAK C., BAYERLE-EDE M. FEMALE SEXUAL DYSFUNCTION. Obstetrics, Gynecology and Reproduction. 2015;9(4):86-88. (In Russ.) https://doi.org/10.17749/2070-4968.2015.9.4.086-088

Views: 52


ISSN 2313-7347 (Print)
ISSN 2500-3194 (Online)